Clinical trials for deep brain stimulation: Current state of affairs

Lozano, 2004, How does DBS work?, Suppl Clin Neurophysiol, 57, 733, 10.1016/S1567-424X(09)70414-3

Hariz, 2017, My 25 stimulating years with DBS in Parkinson’s disease, J Parkinson’s Dis, 7, S33

Lozano, 2013, Probing and regulating dysfunctional circuits using deep brain stimulation, Neuron, 77, 406, 10.1016/j.neuron.2013.01.020

Hu, 2012, Deep brain stimulation in China: present and future, Neuromodulation Technol Neural Interface, 15, 251, 10.1111/j.1525-1403.2012.00439.x

Hu, 2008, Reform of how health care is paid for in China: challenges and opportunities, Lancet, 372, 1846, 10.1016/S0140-6736(08)61368-9

Liu, 2013, Subthalamic deep brain stimulation with a new device in Parkinson’s disease: an open-label trial, Neuromodulation Technol Neural Interface, 16, 212, 10.1111/ner.12050

Guan, 2001, The effect of deep brain stimulation and follow-up treatment on tremor and spasm of Parkinson’s disease, Mod Rehabil J, 33–5

Chen, 2019, Long-term results after deep brain stimulation of nucleus accumbens and the anterior limb of the internal capsule for preventing heroin relapse: an open-label pilot study, Brain Stimul, 12, 175, 10.1016/j.brs.2018.09.006

Ge, 2019, Deep brain stimulation of nucleus accumbens for methamphetamine addiction: two case reports, World Neurosurg, 122, 512, 10.1016/j.wneu.2018.11.056

Koller, 1997, High-frequency unilateral thalamic stimulation in the treatment of essential and parkinsonian tremor, Ann Neurol, 42, 292, 10.1002/ana.410420304

Zhang, 2010, Long-term results of thalamic deep brain stimulation for essential tremor, J Neurosurg, 112, 1271

Limousin, 1998, Electrical stimulation of the subthalamic nucleus in advanced Parkinson’s disease, N Engl J Med, 339, 1105, 10.1056/NEJM199810153391603

Schüpbach, 2019, Quality of life predicts outcome of deep brain stimulation in early Parkinson disease, Neurology, 92, e1109, 10.1212/WNL.0000000000007037

McIntosh, 2016, Cost-utility analysis of deep brain stimulation surgery plus best medical therapy versus best medical therapy in patients with Parkinson’s: economic evaluation alongside the PD SURG trial, Mov Disord, 31, 1173, 10.1002/mds.26423

Harmsen, 2019, Ultra-high-frequency deep brain stimulation at 10,000 Hz improves motor function, Mov Disord, 34, 146, 10.1002/mds.27550

Drobisz, 2019, Deep brain stimulation targets for treating depression, Behav Brain Res, 359, 266, 10.1016/j.bbr.2018.11.004

Aouizerate, 2004, Deep brain stimulation of the ventral caudate nucleus in the treatment of obsessive—compulsive disorder and major depression, J Neurosurg, 101, 682

Hamani, 2008, Memory enhancement induced by hypothalamic/fornix deep brain stimulation, Ann Neurol, 63, 119, 10.1002/ana.21295

Boutet, 2019, Neuroimaging technological advancements for targeting in functional neurosurgery, Curr Neurol Neurosci Rep, 19, 42, 10.1007/s11910-019-0961-8

Hollingworth, 2017, Single electrode deep brain stimulation with dual targeting at dual frequency for the treatment of chronic pain: a case series and review of the literature, Brain Sci, 7, 9, 10.3390/brainsci7010009

Schüpbach, 2017, Directional leads for deep brain stimulation: opportunities and challenges, Mov Disord, 32, 1371, 10.1002/mds.27096

Steigerwald, 2016, Directional deep brain stimulation of the subthalamic nucleus: a pilot study using a novel neurostimulation device, Mov Disord, 31, 1240, 10.1002/mds.26669

Foltynie, 2011, MRI-guided STN DBS in Parkinson’s disease without microelectrode recording: efficacy and safety, J Neurol Neurosurg Psychiatry, 82, 358, 10.1136/jnnp.2010.205542

Lee, 2017, Interventional MRI–guided deep brain stimulation lead implantation, Neurosurg Clin N Am, 28, 535, 10.1016/j.nec.2017.05.007

Shah

Hakoum, 2017, Characteristics of funding of clinical trials: cross-sectional survey and proposed guidance, BMJ Open, 7, 10.1136/bmjopen-2017-015997

Zarin, 2017, Update on trial registration 11 Years after the ICMJE policy was established, N Engl J Med, 376, 383, 10.1056/NEJMsr1601330